Prognostic value of CYFRA 21 − 1 and Ki67 in advanced NSCLC patients with wild-type EGFR

被引：0
作者：
Tao Li
Qi Xie
Yang-Yang Fang
Yi Sun
Xiao Ming Wang
Zhu Luo
Gui-Ling Yan
Jian-Bo He
Xiao-Qun Zheng
机构：
[1] The Second Affiliated and Yuying Children’s Hospital of Wenzhou Medical University,Department of Laboratory Medicine
[2] Wenzhou Medical University,School of Laboratory Medicine and Life Sciences, The Key Laboratory of Laboratory Medicine
[3] Ministry of Education of China,Department of Respiratory Medicine
[4] The Second Affiliated and Yuying Children’s Hospital of Wenzhou Medical University,undefined
来源：
BMC Cancer | / 23卷
关键词：
CYFRA 21 − 1; Ki67; NSCLC; Wild-type EGFR; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
[21]   Prognostic value of automated KI67 scoring in breast cancer: a centralised evaluation of 8088 patients from 10 study groups [J].
Abubakar, Mustapha ;
Orr, Nick ;
Daley, Frances ;
Coulson, Penny ;
Ali, H. Raza ;
Blows, Fiona ;
Benitez, Javier ;
Milne, Roger ;
Brenner, Herman ;
Stegmaier, Christa ;
Mannermaa, Arto ;
Chang-Claude, Jenny ;
Rudolph, Anja ;
Sinn, Peter ;
Couch, Fergus J. ;
Devilee, Peter ;
Tollenaar, Rob A. E. M. ;
Seynaeve, Caroline ;
Figueroa, Jonine ;
Sherman, Mark E. ;
Lissowska, Jolanta ;
Hewitt, Stephen ;
Eccles, Diana ;
Hooning, Maartje J. ;
Hollestelle, Antoinette ;
Martens, John W. M. ;
van Deurzen, Carolien H. M. ;
Bolla, Manjeet K. ;
Wang, Qin ;
Jones, Michael ;
Schoemaker, Minouk ;
Wesseling, Jelle ;
van Leeuwen, Flora E. ;
Van 't Veer, Laura ;
Easton, Douglas ;
Swerdlow, Anthony J. ;
Dowsett, Mitch ;
Pharoah, Paul D. ;
Schmidt, Marjanka K. ;
Garcia-Closas, Montserrat .
BREAST CANCER RESEARCH, 2016, 18
[22]   Prognostic value of Ki67 from clinically and histologically 'normal' distant mucosa in patients surgically treated for oral squamous cell carcinoma: a prospective study [J].
Montebugnoli, L. ;
Badiali, G. ;
Marchetti, C. ;
Cervellati, F. ;
Farnedi, A. ;
Foschini, M. P. .
INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2009, 38 (11) :1165-1172
[23]   Prognostic Value of Ki-67 Expression in Advanced Lung Squamous Cell Carcinoma Patients Treated with Chemotherapy [J].
Wang, Diming ;
Ye, Wei ;
Shi, Qingming .
CANCER MANAGEMENT AND RESEARCH, 2021, 13 :6429-6436
[24]   Prognostic value of combination of Cyfra 21-1, CEA and NSE in patients with advanced non-small cell lung cancer [J].
Barlési, F ;
Gimenez, C ;
Torre, JP ;
Doddoli, C ;
Mancini, J ;
Greillier, L ;
Roux, F ;
Kleisbauer, JP .
RESPIRATORY MEDICINE, 2004, 98 (04) :357-362
[25]   Predictive Role of CEA and CYFRA 21-1 in Patients with Advanced-stage NSCLC Treated with Erlotinib [J].
Fiala, Ondrej ;
Pesek, Milos ;
Finek, Jindrich ;
Benesova, Lucie ;
Minarik, Marek ;
Bortlicek, Zbynek ;
Topolcan, Ondrej .
ANTICANCER RESEARCH, 2014, 34 (06) :3205-3210
[26]   CEA and CYFRA 21-1 as prognostic biomarker and as a tool for treatment monitoring in advanced NSCLC treated with immune checkpoint inhibitors [J].
Dall'Olio, Filippo G. ;
Abbati, Francesca ;
Facchinetti, Francesco ;
Massucci, Maria ;
Melotti, Barbara ;
Squadrilli, Anna ;
Buti, Sebastiano ;
Formica, Francesca ;
Tiseo, Marcello ;
Ardizzoni, Andrea .
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
[27]   Prognostic value of mutant p53, Ki-67, and TTF-1 and their correlation with EGFR mutation in patients with non-small cell lung cancer [J].
Zhu, Wang-Yu ;
Hu, Xiao-Fei ;
Fang, Ke-Xin ;
Kong, Qiong-Qiong ;
Cui, Ri ;
Li, Hai-Feng ;
He, Jian-Ying ;
Zhang, Yong-kui ;
Le, Han-Bo .
HISTOLOGY AND HISTOPATHOLOGY, 2019, 34 (11) :1269-1278
[28]   The prognostic value of Ki67 is dependent on estrogen receptor status and histological grade in premenopausal patients with node-negative breast cancer [J].
Klintman, Marie ;
Bendahl, Par-Ola ;
Grabau, Dorthe ;
Lovgren, Kristina ;
Malmstrom, Per ;
Ferno, Marten .
MODERN PATHOLOGY, 2010, 23 (02) :251-259
[29]   The prognostic value of Ki67 in ovarian high-grade serous carcinoma: an 11-year cohort study of Chinese patients [J].
Chen, Ming ;
Yao, Shuzhong ;
Cao, Qinghua ;
Xia, Meng ;
Liu, Junxiu ;
He, Mian .
ONCOTARGET, 2017, 8 (64) :107877-107885
[30]   Pemetrexed Versus Erlotinib in the Second-line Treatment of Patients with Advanced-stage Non-squamous NSCLC Harboring Wild-type EGFR Gene [J].
Fiala, Ondrej ;
Pesek, Milos ;
Finek, Jindrich ;
Svaton, Martin ;
Minarik, Marek ;
Benesova, Lucie ;
Bortlicek, Zbynek ;
Kucera, Radek ;
Topolcan, Ondrej .
ANTICANCER RESEARCH, 2016, 36 (01) :447-453
12345